Literature DB >> 11384718

Correlation of cleavage of SNAP-25 with muscle function in a rat model of Botulinum neurotoxin type A induced paralysis.

C V Jurasinski1, E Lieth, A N Dang Do, C L Schengrund.   

Abstract

Injection of botulinum neurotoxin serotype A (BoNT/A) into muscle results in cleavage of the synaptosomal associated protein of 25 kDa (SNAP-25) and relatively long-term paralysis. However, nerve-terminal sprouting, which appears to require intact SNAP-25, has been reported to occur much earlier. The difference between the long-term paralysis induced by injection of BoNT/A and the short time needed for sprouting led us to investigate the relationship between BoNT/A catalyzed cleavage of SNAP-25 and muscle function. The effect of BoNT/A on SNAP-25 present in nerve endings innervating gastrocnemius muscles of rats was monitored over time. Cleaved SNAP-25 was found in nerve terminals innervating the muscles within 24h of inoculation with BoNT/A and was present more than 2 months later. Comparison of the ratios of cleaved to intact SNAP-25 from the onset of BoNT/A-induced paralysis until function was regained indicated that paralysis was probable when the ratio of cleaved to intact SNAP-25 was greater than 0.35.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384718     DOI: 10.1016/s0041-0101(01)00082-4

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  12 in total

Review 1.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

Review 2.  Temporal characteristics of botulinum neurotoxin therapy.

Authors:  Frank J Lebeda; Regina Z Cer; Robert M Stephens; Uma Mudunuri
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

3.  The Use of Botulinum Toxin in the Management of Headache Disorders.

Authors:  Hsiangkuo Yuan; Stephen D Silberstein
Journal:  Handb Exp Pharmacol       Date:  2021

4.  The Use of Botulinum Toxins for Chronic Pain and Headaches.

Authors:  Charles E. Argoff
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

Review 5.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

6.  The effects on the mandibular condyle of Botox injection into the masseter are not transient.

Authors:  Eliane H Dutra; Sumit Yadav
Journal:  Am J Orthod Dentofacial Orthop       Date:  2019-08       Impact factor: 2.650

Review 7.  Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

Authors:  Michael B Chancellor; Clare J Fowler; Apostolos Apostolidis; William C de Groat; Christopher P Smith; George T Somogyi; K Roger Aoki
Journal:  Nat Clin Pract Urol       Date:  2008-05-06

8.  Onset dynamics of type A botulinum neurotoxin-induced paralysis.

Authors:  Frank J Lebeda; Michael Adler; Keith Erickson; Yaroslav Chushak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-06-13       Impact factor: 2.745

9.  Plasma membrane localization signals in the light chain of botulinum neurotoxin.

Authors:  Ester Fernández-Salas; Lance E Steward; Helen Ho; Patton E Garay; Sarah W Sun; Marcella A Gilmore; Joseph V Ordas; Joanne Wang; Joseph Francis; K Roger Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays.

Authors:  Maren Schenke; Brit-Maren Schjeide; Gerhard P Püschel; Bettina Seeger
Journal:  Toxins (Basel)       Date:  2020-04-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.